nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—MAOA—Dopamine metabolism—PRKACA—adrenal gland cancer	0.0701	0.0726	CbGpPWpGaD
Rizatriptan—HTR1F—GPCRs, Other—GNRHR—adrenal gland cancer	0.0688	0.0711	CbGpPWpGaD
Rizatriptan—Sumatriptan—ABCB1—adrenal gland cancer	0.0335	1	CrCbGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0256	0.0265	CbGpPWpGaD
Rizatriptan—MAOA—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0206	0.0213	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0195	0.0202	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0164	0.0169	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.016	0.0166	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—KCNJ5—adrenal gland cancer	0.0157	0.0163	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0153	0.0159	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0137	0.0141	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0125	0.0129	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0122	0.0126	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0122	0.0126	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0117	0.0121	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.011	0.0114	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—TSHR—adrenal gland cancer	0.0104	0.0108	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—GNRHR—adrenal gland cancer	0.01	0.0103	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.01	0.0103	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00981	0.0101	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00961	0.00994	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0096	0.00993	CbGpPWpGaD
Rizatriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00953	0.00986	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0093	0.00962	CbGpPWpGaD
Rizatriptan—MAOA—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00913	0.00944	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00874	0.00904	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00856	0.00885	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00817	0.00845	CbGpPWpGaD
Rizatriptan—MAOA—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00788	0.00815	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00747	0.00773	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00731	0.00757	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00731	0.00756	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00704	0.00729	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0069	0.00714	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00673	0.00697	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—TSHR—adrenal gland cancer	0.00666	0.00689	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0066	0.00683	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00652	0.00674	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00652	0.00674	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0064	0.00662	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00639	0.00662	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00626	0.00648	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00626	0.00648	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—GNAS—adrenal gland cancer	0.00605	0.00626	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—PRKACA—adrenal gland cancer	0.00603	0.00624	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00599	0.0062	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GNRHR—adrenal gland cancer	0.00591	0.00611	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00588	0.00609	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00557	0.00576	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00549	0.00568	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00535	0.00554	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—TSHR—adrenal gland cancer	0.00534	0.00553	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00525	0.00544	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00516	0.00534	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00498	0.00516	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00496	0.00514	CbGpPWpGaD
Rizatriptan—MAOA—Biological oxidations—POMC—adrenal gland cancer	0.00485	0.00502	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00477	0.00494	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00477	0.00493	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SDHB—adrenal gland cancer	0.00434	0.00449	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00431	0.00445	CbGpPWpGaD
Rizatriptan—MAOA—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00424	0.00439	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00422	0.00437	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00422	0.00436	CbGpPWpGaD
Rizatriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00415	0.0043	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00413	0.00428	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.0041	0.00424	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—POMC—adrenal gland cancer	0.00408	0.00422	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—GNAS—adrenal gland cancer	0.00387	0.00401	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00383	0.00397	CbGpPWpGaD
Rizatriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00383	0.00397	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00383	0.00396	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00379	0.00392	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GNRHR—adrenal gland cancer	0.00378	0.00391	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00376	0.00389	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00375	0.00388	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00374	0.00387	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GNRHR—adrenal gland cancer	0.0037	0.00383	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00368	0.00381	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00358	0.0037	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GNRH1—adrenal gland cancer	0.00354	0.00366	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00351	0.00363	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00344	0.00356	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00342	0.00354	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00342	0.00354	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—TSHR—adrenal gland cancer	0.00342	0.00353	CbGpPWpGaD
Rizatriptan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00337	0.00348	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00335	0.00347	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00334	0.00346	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0033	0.00342	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—BRAF—adrenal gland cancer	0.00325	0.00336	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CDC42—adrenal gland cancer	0.00325	0.00336	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SPRY2—adrenal gland cancer	0.00324	0.00335	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00323	0.00335	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00321	0.00332	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00318	0.00329	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TSHR—adrenal gland cancer	0.00316	0.00326	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00315	0.00326	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—GNAS—adrenal gland cancer	0.00311	0.00321	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MEN1—adrenal gland cancer	0.00297	0.00307	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.0029	0.003	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.0029	0.003	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00289	0.00299	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00286	0.00296	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00282	0.00292	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00281	0.0029	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SDHD—adrenal gland cancer	0.00279	0.00289	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—RRM1—adrenal gland cancer	0.00279	0.00289	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00262	0.00271	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—POMC—adrenal gland cancer	0.00261	0.0027	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00255	0.00264	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—POMC—adrenal gland cancer	0.00255	0.00264	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00255	0.00264	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00246	0.00255	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00245	0.00254	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0024	0.00248	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—POMC—adrenal gland cancer	0.0023	0.00238	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00229	0.00237	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PRKACA—adrenal gland cancer	0.00226	0.00234	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GNRH1—adrenal gland cancer	0.00226	0.00234	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00224	0.00232	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00222	0.00229	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00219	0.00226	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00214	0.00222	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—POMC—adrenal gland cancer	0.00209	0.00216	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MED12—adrenal gland cancer	0.00208	0.00216	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CDC42—adrenal gland cancer	0.00208	0.00215	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SPRY2—adrenal gland cancer	0.00207	0.00214	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00204	0.00211	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00203	0.0021	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TSHR—adrenal gland cancer	0.00202	0.00209	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—GNAS—adrenal gland cancer	0.00199	0.00206	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TSHR—adrenal gland cancer	0.00198	0.00204	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00195	0.00201	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	0.00194	0.00201	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDC42—adrenal gland cancer	0.00192	0.00199	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MEN1—adrenal gland cancer	0.0019	0.00196	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MEN1—adrenal gland cancer	0.00186	0.00192	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF2—adrenal gland cancer	0.00185	0.00192	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GNAS—adrenal gland cancer	0.00184	0.0019	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00183	0.00189	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF1R—adrenal gland cancer	0.00179	0.00185	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.00179	0.00185	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00173	0.00178	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00171	0.00177	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00169	0.00175	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00163	0.00169	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.0016	0.00165	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00155	0.0016	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00154	0.0016	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TERT—adrenal gland cancer	0.00154	0.00159	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PRKACA—adrenal gland cancer	0.00152	0.00157	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	0.0015	0.00156	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00148	0.00153	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.00147	0.00152	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.00145	0.0015	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.00144	0.00149	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.00142	0.00147	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	0.00141	0.00146	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—BAD—adrenal gland cancer	0.00134	0.00139	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—POMC—adrenal gland cancer	0.00134	0.00138	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	0.00131	0.00136	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00126	0.0013	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—POMC—adrenal gland cancer	0.00124	0.00128	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GNAS—adrenal gland cancer	0.00123	0.00127	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDC42—adrenal gland cancer	0.00123	0.00127	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—BRAF—adrenal gland cancer	0.00122	0.00126	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ABCB1—adrenal gland cancer	0.00121	0.00125	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	0.0012	0.00124	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	0.00118	0.00122	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—EGFR—adrenal gland cancer	0.00118	0.00122	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	0.00117	0.00121	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.00116	0.0012	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.00115	0.00119	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.00114	0.00118	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.00112	0.00116	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.0011	0.00114	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.00108	0.00112	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.00103	0.00107	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.00103	0.00107	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000998	0.00103	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	0.000985	0.00102	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000965	0.000998	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000916	0.000948	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000883	0.000914	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000882	0.000912	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000875	0.000906	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	0.000857	0.000887	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000854	0.000883	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000839	0.000868	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—POMC—adrenal gland cancer	0.000829	0.000858	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.00079	0.000818	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.00078	0.000807	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000774	0.000801	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000768	0.000795	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000764	0.000791	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000756	0.000783	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000741	0.000766	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000735	0.00076	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—adrenal gland cancer	0.000699	0.000723	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000687	0.000711	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—adrenal gland cancer	0.000661	0.000684	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000639	0.000662	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.000589	0.00061	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—adrenal gland cancer	0.000587	0.000607	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000582	0.000602	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000564	0.000584	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000564	0.000584	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.00056	0.00058	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000552	0.000571	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000548	0.000567	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.000454	0.00047	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000447	0.000462	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	0.000446	0.000461	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000437	0.000453	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000421	0.000435	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	0.000375	0.000388	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	0.000367	0.00038	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000333	0.000345	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—POMC—adrenal gland cancer	0.000306	0.000316	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	0.00028	0.00029	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	0.000244	0.000252	CbGpPWpGaD
